Can Improving Bioavailability Improve the Bioactivity of Curcumin?

Hong-Fang Ji,Liang Shen
DOI: https://doi.org/10.1016/j.tips.2014.04.001
IF: 17.638
2014-01-01
Trends in Pharmacological Sciences
Abstract:As the major yellow pigment and active chemical constituent in turmeric, curcumin has been one of the most widely studied natural products. This mainly arises from its wide-ranging pharmacological activities and healthy benefits. The efficacy and safety of curcumin in traditional Indian (Ayruvedic) and Chinese medicine for thousands of years as well as numerous clinical trials in the past decades have suggested its potential therapeutic applications in many diseases. However, curcumin has one major disadvantage: extremely low systemic bioavailability, owing to its low aqueous solubility and poor stability, has severely limited its clinical application. Numerous clinical trials found undetectable or rather low in vivo levels of curcumin after high doses of administration [ 1 Anand P. et al. Bioavailability of curcumin: problems and promises. Mol. Pharm. 2007; 4: 807 Crossref PubMed Scopus (4213) Google Scholar ].
What problem does this paper attempt to address?